Bio-Me has announced that Warren Flood has become CEO following a successful period as COO.

Previous CEO, Morten Isaksen, moves up to the Board and will also continue as Chief Innovation Officer with a focus on longer term and higher value clinical applications for the company’s Precision Microbiome Profiling (PMP) technology, states the company.

“We are really pleased to see how the company has developed with Dr. Isaksen as the CEO. Him stepping up to the Board and focusing on the clinical applications will help us to have stronger focus on the key market segments in the company and is a strategic choice to position the company for further growth,” says Carl-Christian Gilhuus-Moe, Chairman of Bio-Me.

Warren Flood

Warren Flood is a microbiologist with a key interest in the design and development of improved molecular techniques for microbiome analysis and is currently chairman of the Pharmabiotics Research Institute OMICs task group. He holds a PhD in microbiology and a MSc in immunology and immunogenetics from the University of Manchester.

“I am honoured to have been appointed CEO of Bio-Me, particularly at this exciting time in the company’s development. Morten first attracted me to the company and has built excellent foundations for future growth. As COO I have witnessed first-hand the growing interest in PMP™ and look forward to further realizing this potential,” says Warren Flood.

Photo of Warren Flood: Bio-Me